Finally, considering the identified association of ALI-specific key genes with poor prognosis in LUAD/LUSC patients, TIMP1, SERPINE1, PLAUR, and PTX3 may be used as marker genes to control the severity of lung cancer progression in the case of accompanying pulmonary inflammation. The gene discussed is PTX3; the disease is lung carcinoma.